← TruNorth

Agomab Therapeutics NV vs Arcus Biosciences

On overall TruNorth grade, Arcus Biosciences scores higher (Agomab Therapeutics NV: F, Arcus Biosciences: A). Both graded from public records across nine values categories.

F
Agomab Therapeutics NV
0/100
A
Arcus Biosciences
68.8/100

Political donations

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

FEC: $546K in executive political donations; partisan lean split across 20 executive donors.

Environment

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Labor

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

DEI

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Charity

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Animal testing

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Firearms

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Privacy

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

No public record found.

Executive pay

Agomab Therapeutics NV

No public record found.

Arcus Biosciences

CEO-to-median-worker pay ratio 36:1 (median employee pay $269,269) — SEC proxy statement (DEF 14A, 2026).

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →